WPC
RVMD icon

Wedmont Private Capital’s Revolution Medicines RVMD Stock Holding History

Wedmont Private Capital’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.53M Buy
40,281
+50
+0.1% +$7.3K 0.21% 66
2026
Q1 		$3.89M Buy
40,231
+175
+0.4% +$17.7K 0.13% 94
2025
Q4 		$4.11M Buy
40,056
+50
+0.1% +$3.28K 0.14% 85
2025
Q3 		$1.86M Sell
40,006
-9
-0% -$352 0.07% 173
2025
Q2 		$1.54M Buy
40,015
+15
+0% +$576 0.07% 193
2025
Q1 		$1.43M Hold
40,000
– – 0.07% 166
2024
Q4 		$1.67M Sell
40,000
-7,600
-16% -$384K 0.09% 135
2024
Q3 		$2.25M Sell
47,600
-2,000
-4% -$87.1K 0.13% 93
2024
Q2 		$2.24M Hold
49,600
– – 0.14% 90
2024
Q1 		$1.64M Hold
49,600
– – 0.12% 107
2023
Q4 		$1.45M Buy
+49,600
New +$1.19M 0.12% 109

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Wedmont Private Capital's RVMD Position: Q2 2026 in Review

Wedmont Private Capital increased its Revolution Medicines (RVMD) stake by 0.12% in Q2 2026, buying an estimated $7.3K and bringing the position to 40,281 shares worth $7.53M. The position accounts for 0.21% of the portfolio, ranked #66.

Wedmont Private Capital first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Wedmont Private Capital held 40,281 shares of Revolution Medicines worth $7.53M as of Q2 2026.
  • Wedmont Private Capital bought 50 Revolution Medicines shares in Q2 2026, an estimated $7.3K.
  • Revolution Medicines made up 0.21% of Wedmont Private Capital's portfolio in Q2 2026, its #66 holding.
  • Wedmont Private Capital first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.